Clinical Trial Update: A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating safety and efficacy of a tumor vaccine in patients with advanced renal cell carcinoma has completed Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Tumor vaccine (ASET)

Snippet

Sponsor: Mologen AG | Conditions: Stage IV Renal Cell Cancer | Phase 1, Phase 2 | Status: COMPLETED